Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics

Author:

Cronin-Fenton Deirdre P.,Damkier Per

Publisher

Elsevier

Reference113 articles.

1. Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue;Ahern;Clinical Epidemiology,2010

2. Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors;Ahern;Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology,2011

3. Cytochrome P-450 2D6 (CYP2D6) genotype and breast cancer recurrence in tamoxifen-treated patients: Evaluating the importance of loss of heterozygosity;Ahern;American Journal of Epidemiology,2017

4. Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies;Amiri-Kordestani;Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy,2012

5. Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients;Argalacsova;Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3